1-aminomethyl-1-(3,3-dimethylcyclohexane) acetic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1-aminomethyl-1-(3,3-dimethylcyclohexane) acetic acid
• 英文别名: (+/-)-(1-aminomethyl-3,3-dimethyl-cyclohexyl)-acetic acid；(1-aminomethyl-3,3-dimethylcyclohexane)acetic acid；2-[1-(Aminomethyl)-3,3-dimethylcyclohexyl]acetic acid
• 化学式: C₁₁H₂₁NO₂
• 分子量: 199.293
• InChiKey: GLARDDUAAVSVRX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.6
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Prodrugs of GABA analogs, compositions and uses thereof
  申请人：Gallop A. Mark

  公开号：US20060229361A1

  公开（公告）日：2006-10-12

  The present invention provides prodrugs of GABA analogs, pharmaceutical compositions of prodrugs of GABA analogs and methods for making prodrugs of GABA analogs. The present invention also provides methods for using prodrugs of GABA analogs and methods for using pharmaceutical compositions of prodrugs of GABA analogs for treating or preventing common diseases and/or disorders.

  本发明提供了GABA类似物的前药，GABA类似物前药的药物组合物以及制备GABA类似物前药的方法。本发明还提供了使用GABA类似物前药的方法以及使用GABA类似物前药的药物组合物治疗或预防常见疾病和/或疾病的方法。
• Orally administered dosage forms of GABA analog prodrugs having reduced toxicity
  申请人：——

  公开号：US20030083382A1

  公开（公告）日：2003-05-01

  The present invention provides an extended release oral dosage form of prodrugs of gabapentin and other GABA analogs, which dosage forms exhibit reduced toxicity. The dosage forms are particularly useful in administering those prodrugs of gabapentin and other GABA analogs that are metabolized to form an aldehyde. The dosage forms of the invention are useful for treating or preventing diseases and/or disorders for which the parent gabapentin or other GABA analog are known to be therapeutically effective.

  本发明提供了加巴喷丁及其他GABA类似物的前药的延长释放口服剂型，这些剂型表现出较低的毒性。这些剂型特别适用于给予那些被代谢形成醛类物质的加巴喷丁及其他GABA类似物的前药。本发明的剂型适用于治疗或预防已知父体加巴喷丁或其他GABA类似物在治疗上有效的疾病和/或疾病。
• Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
  申请人：——

  公开号：US20040014940A1

  公开（公告）日：2004-01-22

  The synthesis of 1-(acyloxy)-alkyl carbamates of GABA analogs from 1-haloalkyl carbamates of GABA analogs are described. Also described are new 1-haloalkyl carbamates of GABA analogs.

  本文介绍了从GABA类似物的1-卤代烷基氨基甲酸酯合成1-(酰氧基)-烷基氨基甲酸酯的方法。同时还介绍了新的GABA类似物的1-卤代烷基氨基甲酸酯。
• METHODS OF USING PRODRUGS OF PREGABALIN
  申请人：Gallop Mark A.

  公开号：US20120035258A1

  公开（公告）日：2012-02-09

  The present invention provides prodrugs of GABA analogs, pharmaceutical compositions of prodrugs of GABA analogs and methods for making prodrugs of GABA analogs. The present invention also provides methods for using prodrugs of GABA analogs and methods for using pharmaceutical compositions of prodrugs of GABA analogs for treating or preventing common diseases and/or disorders.

  本发明提供了GABA类似物的前药、GABA类似物前药的制药组合物以及制备GABA类似物前药的方法。本发明还提供了使用GABA类似物前药的方法以及使用GABA类似物前药制药组合物治疗或预防常见疾病和/或疾病的方法。
• Methods for Synthesis of Acyloxyalkyl Derivatives of GABA Analogs
  申请人：Raillard P. Stephen

  公开号：US20080058546A1

  公开（公告）日：2008-03-06

  The synthesis of 1-(acyloxy)-alkyl carbamates of GABA analogs from 1-haloalkyl carbamates of GABA analogs are described. Also described are new 1-haloalkyl carbamates of GABA analogs.

  本文描述了从GABA类似物的1-卤代烷基氨基甲酸酯中合成1-(酰氧基)-烷基氨基甲酸酯的方法。同时还描述了新的GABA类似物的1-卤代烷基氨基甲酸酯。